PM&R JOURNAL CLUB 

Topics: Extracorporeal shock wave Botulinum Toxin Type A in the treatment of post stroke upper limb spasticity: A randomized noninferiority trial
Speakers: Lester S. Duplechan, MD

Topics: Efficacy of injected corticosteroid type, dose, and volume for pain in large joints: A narrative review
Speakers: Min Yoo, MD

Date: Wednesday, October 9, 2024
Time: 7:00 – 8:00 am
Location: Teams Link sent to staff

Learning Objectives
Upon completion of this activity, participants should be able to:

1. Assess the usefulness of ESWT in the treatment of spasticity in the post-stroke population.
2. Analyze the potential benefits vs. weaknesses of ESWT as an alternative to botulinum toxin in the treatment of spasticity.
3. Compare the efficacy of ESWT and botulinum toxin utilizing functional, spasticity grading, and range of motion measures.
4. Review different types of steroids and doses for large joint injections.
5. Recommend optimal corticosteroid doses for large joint injections.
6. Identify maximum dose of steroid for specific time periods in the context of various comorbidities.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.